1. Home
  2. GL vs ICLR Comparison

GL vs ICLR Comparison

Compare GL & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globe Life Inc.

GL

Globe Life Inc.

HOLD

Current Price

$154.42

Market Cap

12.9B

Sector

Finance

ML Signal

HOLD

Logo ICON plc

ICLR

ICON plc

HOLD

Current Price

$185.02

Market Cap

13.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GL
ICLR
Founded
1900
1990
Country
United States
Ireland
Employees
N/A
N/A
Industry
Life Insurance
Biotechnology: Commercial Physical & Biological Resarch
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
13.1B
IPO Year
1998
2001

Fundamental Metrics

Financial Performance
Metric
GL
ICLR
Price
$154.42
$185.02
Analyst Decision
Buy
Buy
Analyst Count
11
18
Target Price
★ $193.18
$187.76
AVG Volume (30 Days)
419.2K
★ 858.3K
Earning Date
10-21-2026
10-27-2026
Dividend Yield
★ 0.78%
N/A
EPS Growth
★ 17.84
N/A
EPS
★ 7.04
N/A
Revenue
★ $5,994,318,000.00
N/A
Revenue This Year
$6.63
N/A
Revenue Next Year
$5.95
$3.63
P/E Ratio
$23.90
★ $12.91
Revenue Growth
★ 3.74
N/A
52 Week Low
$127.85
$66.57
52 Week High
$191.55
$203.91

Technical Indicators

Market Signals
Indicator
GL
ICLR
Relative Strength Index (RSI) 25.52 63.96
Support Level $148.25 $157.92
Resistance Level $155.60 $191.00
Average True Range (ATR) 3.76 8.68
MACD -0.27 2.16
Stochastic Oscillator 2.02 81.23

Price Performance

Historical Comparison
GL
ICLR

About GL Globe Life Inc.

Globe Life Inc is an insurance holding company. It provides a variety of life and supplemental health insurance products and annuities to a broad base of customers. The company's core operations are organized into three reportable segments: life insurance, supplemental health insurance and investments. Investment activities, conducted by the investment segment, focus on seeking investments with a yield and term appropriate to support the insurance product obligations. These investments generally consist of fixed maturities and, over the long term, the expected yields are considered when setting insurance premium rates and product profitability expectations.

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Share on Social Networks: